Targeting tumor angiogenesis with histone deacetylase inhibitors.


Solid tumor malignancies including breast, lung and prostate carcinomas are considered to be angiogenesis dependent. Tumor angiogenesis is often mediated by hypoxia secondary to tumor growth or by increased oncogenic signaling. Both mechanisms result in increased hypoxia-inducible factor-1 alpha (HIF-1alpha) signaling and its transcriptional target vascular… (More)
DOI: 10.1016/j.canlet.2008.11.012


Cite this paper

@article{Ellis2009TargetingTA, title={Targeting tumor angiogenesis with histone deacetylase inhibitors.}, author={Leigh Ellis and Hans J. Hammers and Roberto Pili}, journal={Cancer letters}, year={2009}, volume={280 2}, pages={145-53} }